{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:36:10Z","timestamp":1791488170929,"version":"4.3.4"},"reference-count":103,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMP"],"published-print":{"date-parts":[[2021,8,16]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Vulvovaginal candidiasis (VVC) is a common vaginal infection caused by\ncandida species, affecting 70% of the women. It may occur due to the imbalance in the vaginal micro-\nbiodata, pregnancy, diabetes, use of antibiotics, frequent sexual activities or AIDS.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Aim:<\/jats:title>\n<jats:p>The main aim of this review is to provide overview about different vaginal delivery systems\nfor the administration of antifungal agents like conventional, mucoadhesive and muco-penetrating\ndelivery systems.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Method:<\/jats:title>\n<jats:p>The conventional delivery systems available have limited efficacy due to the less residence\ntime and adverse effects. In order to overcome these issues, a delivery system with mucoadhesive\nand muco-penetrating properties is required. Mucoadhesive polymers have excellent binding\nproperties with mucin and thus increasing residence time. On the other hand, muco-penetrating polymers\ntransport the antifungal agents across the mucus layer.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p> This review summarizes the pathophysiology of VVC along with novel delivery systems\nfor the treatment of infection through mucoadhesive and muco-penetrating approaches. Surface\nmodifications of nano\/ microparticles with mucoadhesive or muco-penetrating particles may\nprovide delivery systems with improved therapeutic efficacy.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Based on the available data, conventional and mucoadhesive drug delivery systems\nhave some limitations, they still require improvement\/ development for safe and effective delivery\nof antifungal agents.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573405616666200621200047","type":"journal-article","created":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T07:52:21Z","timestamp":1592812341000},"page":"281-291","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Recent Advances in Vaginal Delivery for the Treatment of Vulvovaginal Candidiasis"],"prefix":"10.1016","volume":"14","author":[{"given":"Sandeep","family":"Kaur","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics, ISF College of Pharmacy, Moga (Punjab), India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhbir","family":"Kaur","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, ISF College of Pharmacy, Moga (Punjab), India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"ref=1","first-page":"3","volume":"10","author":"Dobaria N.","year":"2007","unstructured":"Dobaria N.; Mashru R.; Vadia N.H.; Vaginal drug delivery systems: A review of current status. East Cent Afr J Pharm Sci 2007,10(1),3-13","journal-title":"East Cent Afr J Pharm Sci"},{"key":"ref=2","first-page":"1033","volume":"3","author":"Choudhury A.","year":"2011","unstructured":"Choudhury A.; Das S.; Kar M.; A review on novelty and potentiality of vaginal drug delivery. Int J Pharm Tech Res 2011,3,1033-1044","journal-title":"Int J Pharm Tech Res"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0378-5173(01)00637-8","volume":"219","author":"Paveli\u0107 Z.","year":"2001","unstructured":"Paveli\u0107 Z.; \u0160kalko-Basnet N.; Schubert R.; Liposomal gels for vaginal drug delivery. Int J Pharm 2001,219(1-2),139-149","journal-title":"Int J Pharm"},{"key":"ref=4","first-page":"184","volume":"3","author":"Keshwani B.","year":"2014","unstructured":"Keshwani B.; Sharma D.; Chatterjee A.; Jamini M.; Arora P.; Novel Concepts in Vaginal Drug Delivery. J Pharma Res 2014,3(10),184-187","journal-title":"J Pharma Res"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12905-015-0197-y","volume":"15","author":"Mulu W","year":"2015","unstructured":"Mulu W; Yimer M; Zenebe Y; Abera B; Common causes of vaginal infections and antibiotic susceptibility of aerobic bacterial isolates in women of reproductive age attending at Felegehiwot referral Hospital, Ethiopia: a cross sectional study. BMC women's health 2015,15(1),42","journal-title":"BMC women's health"},{"key":"ref=6","first-page":"744","volume":"83","author":"Haltas H.","year":"2012","unstructured":"Haltas H.; Bayrak R.; Yenidunya S.; To determine of the prevalence of Bacterial Vaginosis, Candida sp, mixed infections (Bacterial Vaginosis + Candida sp), Trichomonas Vaginalis, Actinomyces sp in Turkish women from Ankara, Turkey. Ginekol Pol 2012,83(10),744-748","journal-title":"Ginekol Pol"},{"key":"ref=7","first-page":"S1","volume":"21","author":"Berry M.","year":"2005","unstructured":"Berry M.; Vaginal infections: an overview. Pharm Pract (Granada) 2005,21(9),S1-S8","journal-title":"Pharm Pract (Granada)"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.2165\/00003495-200868130-00002","volume":"68","author":"das Neves J.","year":"2008","unstructured":"das Neves J.; Pinto E.; Teixeira B.; Dias G.; Rocha P.; Cunha T.; Santos B.; Amaral M.H.; Bahia M.F.; Local treatment of vulvovaginal candidosis : general and practical considerations. Drugs 2008,68(13),1787-1802","journal-title":"Drugs"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1111\/j.1462-5822.2009.01319.x","volume":"11","author":"Moreno-Ruiz E.","year":"2009","unstructured":"Moreno-Ruiz E.; Gal\u00e1n-D\u00edez M.; Zhu W.; Fern\u00e1ndez-Ruiz E.; d\u2019Enfert C.; Filler S.G.; Cossart P.; Veiga E.; Candida albicans internalization by host cells is mediated by a clathrin-dependent mechanism. Cell Microbiol 2009,11(8),1179-1189","journal-title":"Cell Microbiol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.micinf.2011.06.009","volume":"13","author":"Naglik J.R.","year":"2011","unstructured":"Naglik J.R.; Moyes D.L.; W\u00e4chtler B.; Hube B.; Candida albicans interactions with epithelial cells and mucosal immunity. Microbes Infect 2011,13(12-13),963-976","journal-title":"Microbes Infect"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1080\/21505594.2015.1012981","volume":"6","author":"Moyes D.L.","year":"2015","unstructured":"Moyes D.L.; Richardson J.P.; Naglik J.R.; Candida albicans-epithelial interactions and pathogenicity mechanisms: scratching the surface. Virulence 2015,6(4),338-346","journal-title":"Virulence"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/yea.1111","volume":"21","author":"Loza L.","year":"2004","unstructured":"Loza L.; Fu Y.; Ibrahim A.S.; Sheppard D.C.; Filler S.G.; Edwards J.E.; Functional analysis of the Candida albicans ALS1 gene product. Yeast 2004,21(6),473-482","journal-title":"Yeast"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1128\/EC.00120-06","volume":"5","author":"Rauceo J.M.","year":"2006","unstructured":"Rauceo J.M.; De Armond R.; Otoo H.; Kahn P.C.; Klotz S.A.; Gaur N.K.; Lipke P.N.; Threonine-rich repeats increase fibronectin binding in the Candida albicans adhesin Als5p. Eukaryot Cell 2006,5(10),1664-1673","journal-title":"Eukaryot Cell"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13693780701435317","volume":"46","author":"Hoyer L.L.","year":"2008","unstructured":"Hoyer L.L.; Green C.B.; Oh S.H.; Zhao X.; Discovering the secrets of the Candida albicans agglutinin-like sequence (ALS) gene family--a sticky pursuit. Med Mycol 2008,46(1),1-15","journal-title":"Med Mycol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1128\/EC.00279-10","volume":"10","author":"Liu Y.","year":"2011","unstructured":"Liu Y.; Filler S.G.; Candida albicans Als3, a multifunctional adhesin and invasin. Eukaryot Cell 2011,10(2),168-173","journal-title":"Eukaryot Cell"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"10455","DOI":"10.1074\/jbc.M412592200","volume":"280","author":"Phan Q.T.","year":"2005","unstructured":"Phan Q.T.; Fratti R.A.; Prasadarao N.V.; Edwards J.E.; Filler S.G.; N-cadherin mediates endocytosis of Candida albicans by endothelial cells. J Biol Chem 2005,280(11),10455-10461","journal-title":"J Biol Chem"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3109\/10717544.2014.928760","volume":"23","author":"Johal H.S.","year":"2016","unstructured":"Johal H.S.; Garg T.; Rath G.; Goyal A.K.; Advanced topical drug delivery system for the management of vaginal candidiasis. Drug Deliv 2016,23(2),550-563","journal-title":"Drug Deliv"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1086\/314822","volume":"180","author":"Spreghini E.","year":"1999","unstructured":"Spreghini E.; Gismondi A.; Piccoli M.; Santoni G.; Evidence for alphavbeta3 and alphavbeta5 integrin-like vitronectin (VN) receptors in Candida albicans and their involvement in yeast cell adhesion to VN. J Infect Dis 1999,180(1),156-166","journal-title":"J Infect Dis"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1177\/154405910808701011","volume":"87","author":"Diamond G.","year":"2008","unstructured":"Diamond G.; Beckloff N.; Ryan L.K.; Host defense peptides in the oral cavity and the lung: similarities and differences. J Dent Res 2008,87(10),915-927","journal-title":"J Dent Res"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.chom.2010.08.002","volume":"8","author":"Moyes D.L.","year":"2010","unstructured":"Moyes D.L.; Runglall M.; Murciano C.; Shen C.; Nayar D.; Thavaraj S.; Kohli A.; Islam A.; Mora-Montes H.; Challacombe S.J.; Naglik J.R.; A biphasic innate immune MAPK response discriminates between the yeast and hyphal forms of Candida albicans in epithelial cells. Cell Host Microbe 2010,8(3),225-235","journal-title":"Cell Host Microbe"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00430-011-0209-y","volume":"201","author":"Moyes D.L.","year":"2012","unstructured":"Moyes D.L.; Murciano C.; Runglall M.; Kohli A.; Islam A.; Naglik J.R.; Activation of MAPK\/c-Fos induced responses in oral epithelial cells is specific to Candida albicans and Candida dubliniensis hyphae. Med Microbiol Immunol (Berl) 2012,201(1),93-101","journal-title":"Med Microbiol Immunol (Berl)"},{"key":"ref=22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001181","volume":"6","author":"Sun J.N.","year":"2010","unstructured":"Sun J.N.; Solis N.V.; Phan Q.T.; Bajwa J.S.; Kashleva H.; Thompson A.; Liu Y.; Dongari-Bagtzoglou A.; Edgerton M.; Filler S.G.; Host cell invasion and virulence mediated by Candida albicans Ssa1. PLoS Pathog 2010,6(11)","journal-title":"PLoS Pathog"},{"key":"ref=23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017046","volume":"6","author":"W\u00e4chtler B.","year":"2011","unstructured":"W\u00e4chtler B.; Wilson D.; Haedicke K.; Dalle F.; Hube B.; From attachment to damage: defined genes of Candida albicans mediate adhesion, invasion and damage during interaction with oral epithelial cells. PLoS One 2011,6(2)","journal-title":"PLoS One"},{"key":"ref=24","first-page":"43","volume":"1","author":"Sahoo C.K.","year":"2013","unstructured":"Sahoo C.K.; Nayak P.K.; Sarangi D.K.; Sahoo T.K.; Intra vaginal drug delivery system: An overview. Am J Adv Drug Deliv 2013,1,43-55","journal-title":"Am J Adv Drug Deliv"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/myc.12455","volume":"59","author":"Chew S.Y.","year":"2016","unstructured":"Chew S.Y.; Than L.T.; Vulvovaginal candidosis: Contemporary challenges and the future of prophylactic and therapeutic approaches. Mycoses 2016,59(5),262-273","journal-title":"Mycoses"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3109\/21691401.2014.885442","volume":"43","author":"Singh H.","year":"2015","unstructured":"Singh H.; Sharma R.; Joshi M.; Garg T.; Goyal A.K.; Rath G.; Transmucosal delivery of Docetaxel by mucoadhesive polymeric nanofibers. Artif Cells Nanomed Biotechnol 2015,43(4),263-269","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.addr.2014.12.004","volume":"92","author":"das Neves J.","year":"2015","unstructured":"das Neves J.; Nunes R.; Machado A.; Sarmento B.; Polymer-based nanocarriers for vaginal drug delivery. Adv Drug Deliv Rev 2015,92,53-70","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.3390\/ijms19061549","volume":"19","author":"Leyva-G\u00f3mez G.","year":"2018","unstructured":"Leyva-G\u00f3mez G.; Pi\u00f1\u00f3n-Segundo E.; Mendoza-Mu\u00f1oz N.; Zambrano-Zaragoza M.L.; Mendoza-Elvira S.; Quintanar-Guerrero D.; Mendoza- Elvira S, Quintanar-Guerrero D. Approaches in polymeric nanoparticles for vaginal drug delivery: A review of the state of the art. Int J Mol Sci 2018,19(6),1549","journal-title":"Int J Mol Sci"},{"key":"ref=29","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3003453","volume":"4","author":"Ensign L.M.","year":"2012","unstructured":"Ensign L.M.; Tang B.C.; Wang Y.Y.; Tse T.A.; Hoen T.; Cone R.; Hanes J.; Mucus-penetrating nanoparticles for vaginal drug delivery protect against herpes simplex virus. Sci Transl Med 2012,4(138)","journal-title":"Sci Transl Med"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/wnan.144","volume":"3","author":"das Neves J.","year":"2011","unstructured":"das Neves J.; Amiji M.; Sarmento B.; Mucoadhesive nanosystems for vaginal microbicide development: friend or foe? Wiley Interdiscip Rev Nanomed Nanobiotechnol 2011,3(4),389-399","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1166\/jnn.2014.9015","volume":"14","author":"Fr\u00f6hlich E.","year":"2014","unstructured":"Fr\u00f6hlich E.; Roblegg E.; Mucus as barrier for drug delivery by nanoparticles. J Nanosci Nanotechnol 2014,14(1),126-136","journal-title":"J Nanosci Nanotechnol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1517\/17425247.2014.924499","volume":"11","author":"Wong T.W.","year":"2014","unstructured":"Wong T.W.; Dhanawat M.; Rathbone M.J.; Vaginal drug delivery: strategies and concerns in polymeric nanoparticle development. Expert Opin Drug Deliv 2014,11(9),1419-1434","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/978-1-4614-9524-6_3","author":"Zhang H.","year":"2014","unstructured":"Zhang H.; Shahbazi M.A.; Almeida P.V.; Santos H.A.;  Mucosal Delivery of Biopharmaceuticals 2014,59-97.","journal-title":"Mucosal Delivery of Biopharmaceuticals"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","volume":"61","author":"Lai S.K.","year":"2009","unstructured":"Lai S.K.; Wang Y.Y.; Hanes J.; Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. Adv Drug Deliv Rev 2009,61(2),158-171","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1115\/1.2206198","volume":"128","author":"Kieweg S.L.","year":"2006","unstructured":"Kieweg S.L.; Katz D.F.; Squeezing flows of vaginal gel formulations relevant to microbicide drug delivery. J Biomech Eng 2006,128(4),540-553","journal-title":"J Biomech Eng"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3109\/03639045.2011.623355","volume":"38","author":"de Ara\u00fajo Pereira R.R.","year":"2012","unstructured":"de Ara\u00fajo Pereira R.R.; Bruschi M.L.; Vaginal mucoadhesive drug delivery systems. Drug Dev Ind Pharm 2012,38(6),643-652","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jconrel.2004.11.034","volume":"103","author":"Hussain A.","year":"2005","unstructured":"Hussain A.; Ahsan F.; The vagina as a route for systemic drug delivery. J Control Release 2005,103(2),301-313","journal-title":"J Control Release"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1016\/j.addr.2005.07.004","volume":"57","author":"Valenta C.","year":"2005","unstructured":"Valenta C.; The use of mucoadhesive polymers in vaginal delivery. Adv Drug Deliv Rev 2005,57(11),1692-1712","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ejpb.2008.09.028","volume":"71","author":"Andrews G.P.","year":"2009","unstructured":"Andrews G.P.; Laverty T.P.; Jones D.S.; Mucoadhesive polymeric platforms for controlled drug delivery. Eur J Pharm Biopharm 2009,71(3),505-518","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijpharm.2009.01.006","volume":"372","author":"Jones D.S.","year":"2009","unstructured":"Jones D.S.; Bruschi M.L.; de Freitas O.; Gremi\u00e3o M.P.; Lara E.H.; Andrews G.P.; Rheological, mechanical and mucoadhesive properties of thermoresponsive, bioadhesive binary mixtures composed of poloxamer 407 and carbopol 974P designed as platforms for implantable drug delivery systems for use in the oral cavity. Int J Pharm 2009,372(1-2),49-58","journal-title":"Int J Pharm"},{"key":"ref=41","author":"Rowe R.C.","year":"2006","unstructured":"Rowe R.C.; Sheskey P.J.; Owen S.C.;  Handbook of pharmaceutical excipients 2006","journal-title":"Handbook of pharmaceutical excipients"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2174\/187221109789105658","volume":"3","author":"Acart\u00fcrk F.","year":"2009","unstructured":"Acart\u00fcrk F.; Mucoadhesive vaginal drug delivery systems. Recent Pat Drug Deliv Formul 2009,3(3),193-205","journal-title":"Recent Pat Drug Deliv Formul"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0168-3659(03)00339-0","volume":"93","author":"Bernkop-Schn\u00fcrch A.","year":"2003","unstructured":"Bernkop-Schn\u00fcrch A.; Egger C.; Elhassan Imam M.; Krauland A.H.; Preparation and in vitro characterization of poly(acrylic acid)-cysteine microparticles. J Control Release 2003,93(1),29-38","journal-title":"J Control Release"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1163\/156856209X435835","volume":"21","author":"Cho W.J.","year":"2010","unstructured":"Cho W.J.; Oh S.H.; Lee J.H.; Alginate film as a novel post-surgical tissue adhesion barrier. J Biomater Sci Polym Ed 2010,21(6-7),701-713","journal-title":"J Biomater Sci Polym Ed"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1016\/j.biomaterials.2012.01.007","volume":"33","author":"Pawar S.N.","year":"2012","unstructured":"Pawar S.N.; Edgar K.J.; Alginate derivatization: a review of chemistry, properties and applications. Biomaterials 2012,33(11),3279-3305","journal-title":"Biomaterials"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ejpb.2015.11.003","volume":"98","author":"Netsomboon K.","year":"2016","unstructured":"Netsomboon K.; Bernkop-Schn\u00fcrch A.; Mucoadhesive vs. mucopenetrating particulate drug delivery. Eur J Pharm Biopharm 2016,98,76-89","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3109\/08982104.2013.826242","volume":"24","author":"Vani\u0107 \u017d.","year":"2014","unstructured":"Vani\u0107 \u017d.; Hurler J.; Ferderber K.; Golja Ga\u0161parovi\u0107 P.; \u0160kalko-Basnet N.; Filipovi\u0107-Gr\u010di\u0107 J.; Novel vaginal drug delivery system: deformable propylene glycol liposomes-in-hydrogel. J Liposome Res 2014,24(1),27-36","journal-title":"J Liposome Res"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/j.addr.2005.07.006","volume":"57","author":"Grabovac V.","year":"2005","unstructured":"Grabovac V.; Guggi D.; Bernkop-Schn\u00fcrch A.; Comparison of the mucoadhesive properties of various polymers. Adv Drug Deliv Rev 2005,57(11),1713-1723","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ijpharm.2006.06.027","volume":"325","author":"Sigurdsson H.H.","year":"2006","unstructured":"Sigurdsson H.H.; Loftsson T.; Lehr C.M.; Assessment of mucoadhesion by a resonant mirror biosensor. Int J Pharm 2006,325(1-2),75-81","journal-title":"Int J Pharm"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ejpb.2012.10.008","volume":"83","author":"Rahmat D.","year":"2013","unstructured":"Rahmat D.; M\u00fcller C.; Barthelmes J.; Shahnaz G.; Martien R.; Bernkop-Schn\u00fcrch A.; Thiolated hydroxyethyl cellulose: design and in vitro evaluation of mucoadhesive and permeation enhancing nanoparticles. Eur J Pharm Biopharm 2013,83(2),149-155","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1016\/j.progpolymsci.2014.07.010","volume":"39","author":"Sosnik A.","year":"2014","unstructured":"Sosnik A.; das Neves J, Sarmento B. Mucoadhesive polymers in the design of nano-drug delivery systems for administration by non-parenteral routes: a review. Prog Polym Sci 2014,39(12),2030-2075","journal-title":"Prog Polym Sci"},{"key":"ref=52","first-page":"550","volume":"1","author":"Sundar Raj A.A.","year":"2012","unstructured":"Sundar Raj A.A.; Rubila S.; Jayabalan R.; Ranganathan T.V.; A review on pectin: Chemistry due to general properties of pectin and its pharmaceutical uses. Sci Rep 2012,1,550-551","journal-title":"Sci Rep"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1021\/bm800276d","volume":"9","author":"Sogias I.A.","year":"2008","unstructured":"Sogias I.A.; Williams A.C.; Khutoryanskiy V.V.; Why is chitosan mucoadhesive? Biomacromolecules 2008,9(7),1837-1842","journal-title":"Biomacromolecules"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.progpolymsci.2009.04.001","volume":"34","author":"Pillai C.K.","year":"2009","unstructured":"Pillai C.K.; Paul W.; Sharma C.P.; Chitin and chitosan polymers: Chemistry, solubility and fiber formation. Prog Polym Sci 2009,34(7),641-678","journal-title":"Prog Polym Sci"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ejpb.2011.09.010","volume":"80","author":"Iqbal J.","year":"2012","unstructured":"Iqbal J.; Shahnaz G.; Perera G.; Hintzen F.; Sarti F.; Bernkop-Schn\u00fcrch A.; Thiolated chitosan: development and in vivo evaluation of an oral delivery system for leuprolide. Eur J Pharm Biopharm 2012,80(1),95-102","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2174\/156720111795256129","volume":"8","author":"Foldvari M.","year":"2011","unstructured":"Foldvari M.; Badea I.; Kumar P.; Wettig S.; Batta R.; King M.J.; He Z.; Yeboah E.; Gaspar K.; Hull P.; Shear N.H.; Biphasic vesicles for topical delivery of interferon alpha in human volunteers and treatment of patients with human papillomavirus infections. Curr Drug Deliv 2011,8(3),307-319","journal-title":"Curr Drug Deliv"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ejps.2013.04.035","volume":"50","author":"Vani\u0107 \u017d.","year":"2013","unstructured":"Vani\u0107 \u017d.; \u0160kalko-Basnet N.; Nanopharmaceuticals for improved topical vaginal therapy: can they deliver? Eur J Pharm Sci 2013,50(1),29-41","journal-title":"Eur J Pharm Sci"},{"key":"ref=58","first-page":"1330","volume":"8","author":"Rahman S.S.","year":"2016","unstructured":"Rahman S.S.; Ahmed A.B.; Vaginal Drug Delivery System a Promising Approach for Antiretroviral Drug in the Prevention of HIV Infection: A Review. Journal of Pharmaceutical Sciences and Research 2016,8(12),1330","journal-title":"Journal of Pharmaceutical Sciences and Research"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1166\/jbn.2014.1890","volume":"10","author":"da Silva P.B.","year":"2014","unstructured":"da Silva P.B.; Ramos M.A.; Bonif\u00e1cio B.V.; Negri K.M.; Sato M.R.; Bauab T.M.; Chorilli M.; Chorilli M.; Nanotechnological strategies for vaginal administration of drugs--a review. J Biomed Nanotechnol 2014,10(9),2218-2243","journal-title":"J Biomed Nanotechnol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.farmac.2003.11.018","volume":"59","author":"Karasulu H.Y.","year":"2004","unstructured":"Karasulu H.Y.; Hilmio\u011flu S.; Metin D.Y.; G\u00fcneri T.; Efficacy of a new ketoconazole bioadhesive vaginal tablet on Candida albicans. Farmaco 2004,59(2),163-167","journal-title":"Farmaco"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ijpharm.2009.05.016","volume":"377","author":"Perioli L","year":"2009","unstructured":"Perioli L; Ambrogi V; Pagano C; Scuota S; Rossi C.; FG90 chitosan as a new polymer for metronidazole mucoadhesive tablets for vaginal administration. International journal of pharmaceutics 2009,377(1-2),120-127","journal-title":"International journal of pharmaceutics"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.contraception.2007.11.016","volume":"77","author":"Mauck C.K.","year":"2008","unstructured":"Mauck C.K.; Katz D.; Sandefer E.P.; Nasution M.D.; Henderson M.; Digenis G.A.; Su I.; Page R.; Barnhart K.; Vaginal distribution of Replens and K-Y Jelly using three imaging techniques. Contraception 2008,77(3),195-204","journal-title":"Contraception"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.msec.2017.05.030","volume":"79","author":"de Lima J.A.","year":"2017","unstructured":"de Lima J.A.; Paines T.C.; Motta M.H.; Weber W.B.; Dos Santos S.S.; Cruz L.; da Silva C.B.; Novel Pemulen\/Pullulan blended hydrogel containing clotrimazole-loaded cationic nanocapsules: Evaluation of mucoadhesion and vaginal permeation. Mater Sci Eng C 2017,79,886-893","journal-title":"Mater Sci Eng C"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.colsurfa.2013.12.006","volume":"444","author":"Li Y.","year":"2014","unstructured":"Li Y.; Zhao H.; Duan L.R.; Li H.; Yang Q.; Tu H.H.; Cao W.; Wang S.W.; Preparation, characterization and evaluation of bufalin liposomes coated with citrus pectin. Colloids Surf A Physicochem Eng Asp 2014,444,54-62","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ejpb.2016.12.029","volume":"113","author":"J\u00f8raholmen M.W.","year":"2017","unstructured":"J\u00f8raholmen M.W.; Basnet P.; Acharya G.; \u0160kalko-Basnet N.; PEGylated liposomes for topical vaginal therapy improve delivery of interferon alpha. Eur J Pharm Biopharm 2017,113,132-139","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=66","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3109\/10717544.2010.549526","volume":"18","author":"Wang J.","year":"2011","unstructured":"Wang J.; Huang G.; Preparation of itraconazole-loaded liposomes coated by carboxymethyl chitosan and its pharmacokinetics and tissue distribution. Drug Deliv 2011,18(8),631-638","journal-title":"Drug Deliv"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"15","DOI":"10.14227\/DT180311P15","volume":"18","author":"Marques M.R.","year":"2011","unstructured":"Marques M.R.; Loebenberg R.; Almukainzi M.; Simulated biological fluids with possible application in dissolution testing. Dissolut Technol 2011,18(3),15-28","journal-title":"Dissolut Technol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.nano.2009.05.009","volume":"6","author":"Das R.K.","year":"2010","unstructured":"Das R.K.; Kasoju N.; Bora U.; Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells. Nanomedicine (Lond) 2010,6(1),153-160","journal-title":"Nanomedicine (Lond)"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"3714329","DOI":"10.1155\/2018\/3714329","volume":"2018","author":"Kenechukwu F.C.","year":"2018","unstructured":"Kenechukwu F.C.; Attama A.A.; Ibezim E.C.; Nnamani P.O.; Umeyor C.E.; Uronnachi E.M.; Momoh M.A.; Akpa P.A.; Ozioko A.C.; Novel intravaginal drug delivery system based on molecularly pegylated lipid matrices for improved antifungal activity of miconazole nitrate. BioMed Res Int 2018,2018,3714329","journal-title":"BioMed Res Int"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1166\/jbn.2018.2574","volume":"14","author":"Lucena P.A.","year":"2018","unstructured":"Lucena P.A.; Nascimento T.L.; Gaeti M.P.N.; de \u00c1vila R.I.; Mendes L.P.; Vieira M.S.; Fabrini D.; Amaral A.C.; Lima E.M.; In vivo Vaginal Fungal Load Reduction After Treatment with Itraconazole-Loaded Polycaprolactone-Nanoparticles. J Biomed Nanotechnol 2018,14(7),1347-1358","journal-title":"J Biomed Nanotechnol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1016\/j.xphs.2018.06.017","volume":"107","author":"Souza R.O.","year":"2018","unstructured":"Souza R.O.; Henrique de Lima T.; Or\u00e9fice R.L.; de Freitas Ara\u00fajo M.G.; de Lima Moura S.A.; Magalh\u00e3es J.T.; da Silva G.R.; Amphotericin B-Loaded Poly(lactic-co-glycolic acid) Nanofibers: An Alternative Therapy Scheme for Local Treatment of Vulvovaginal Candidiasis. J Pharm Sci 2018,107(10),2674-2685","journal-title":"J Pharm Sci"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.colsurfb.2014.01.011","volume":"116","author":"Santos S.S.","year":"2014","unstructured":"Santos S.S.; Lorenzoni A.; Pegoraro N.S.; Denardi L.B.; Alves S.H.; Schaffazick S.R.; Cruz L.; Formulation and in vitro evaluation of coconut oil-core cationic nanocapsules intended for vaginal delivery of clotrimazole. Colloids Surf B Biointerfaces 2014,116,270-276","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3109\/21691401.2014.966194","volume":"44","author":"Sharma R.","year":"2016","unstructured":"Sharma R.; Garg T.; Goyal A.K.; Rath G.; Development, optimization and evaluation of polymeric electrospun nanofiber: A tool for local delivery of fluconazole for management of vaginal candidiasis. Artif Cells Nanomed Biotechnol 2016,44(2),524-531","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ejps.2017.11.012","volume":"112","author":"Abruzzo A.","year":"2018","unstructured":"Abruzzo A.; Giordani B.; Parolin C.; Vitali B.; Protti M.; Mercolini L.; Cappelletti M.; Fedi S.; Bigucci F.; Cerchiara T.; Luppi B.; Novel mixed vesicles containing lactobacilli biosurfactant for vaginal delivery of an anti-Candida agent. Eur J Pharm Sci 2018,112,95-101","journal-title":"Eur J Pharm Sci"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.ijbiomac.2014.05.033","volume":"69","author":"Cevher E.","year":"2014","unstructured":"Cevher E.; A\u00e7ma A.; Sinani G.; Aksu B.; Zloh M.; M\u00fclaz\u0131mo\u011flu L.; Bioadhesive tablets containing cyclodextrin complex of itraconazole for the treatment of vaginal candidiasis. Int J Biol Macromol 2014,69,124-136","journal-title":"Int J Biol Macromol"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ejpb.2015.07.018","volume":"96","author":"Bassi P.","year":"2015","unstructured":"Bassi P.; Kaur G.; Bioadhesive vaginal drug delivery of nystatin using a derivatized polymer: Development and characterization. Eur J Pharm Biopharm 2015,96,173-184","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.3109\/03639045.2012.707204","volume":"39","author":"Karimunnisa S.","year":"2013","unstructured":"Karimunnisa S.; Atmaram P.; Mucoadhesive nanoliposomal formulation for vaginal delivery of an antifungal. Drug Dev Ind Pharm 2013,39(9),1328-1337","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.3109\/03639045.2012.694589","volume":"39","author":"Parodi B.","year":"2013","unstructured":"Parodi B.; Russo E.; Caviglioli G.; Baldassari S.; Gaglianone N.; Schito A.M.; Cafaggi S.; A chitosan lactate\/poloxamer 407-based matrix containing Eudragit RS microparticles for vaginal delivery of econazole: design and in vitro evaluation. Drug Dev Ind Pharm 2013,39(12),1911-1920","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ejps.2017.11.029","volume":"115","author":"Mart\u00ednez-P\u00e9rez B.","year":"2018","unstructured":"Mart\u00ednez-P\u00e9rez B.; Quintanar-Guerrero D.; Tapia-Tapia M.; Cisneros-Tamayo R.; Zambrano-Zaragoza M.L.; Alcal\u00e1-Alcal\u00e1 S.; Mendoza-Mu\u00f1oz N.; Pi\u00f1\u00f3n-Segundo E.; Controlled-release biodegradable nanoparticles: From preparation to vaginal applications. Eur J Pharm Sci 2018,115,185-195","journal-title":"Eur J Pharm Sci"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.carbpol.2013.01.005","volume":"94","author":"Mart\u00edn-Villena M.J.","year":"2013","unstructured":"Mart\u00edn-Villena M.J.; Fern\u00e1ndez-Campos F.; Calpena-Campmany A.C.; Bozal-de Febrer N.; Ruiz-Mart\u00ednez M.A.; Clares-Naveros B.; Novel microparticulate systems for the vaginal delivery of nystatin: Development and characterization. Carbohydr Polym 2013,94(1),1-11","journal-title":"Carbohydr Polym"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.ejps.2008.12.009","volume":"36","author":"Albertini B.","year":"2009","unstructured":"Albertini B.; Passerini N.; Di Sabatino M.; Vitali B.; Brigidi P.; Rodriguez L.; Polymer-lipid based mucoadhesive microspheres prepared by spray-congealing for the vaginal delivery of econazole nitrate. Eur J Pharm Sci 2009,36(4-5),591-601","journal-title":"Eur J Pharm Sci"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S0168-3659(02)00086-X","volume":"82","author":"Chang J.Y.","year":"2002","unstructured":"Chang J.Y.; Oh Y.K.; Kong H.S.; Kim E.J.; Jang D.D.; Nam K.T.; Kim C.K.; Prolonged antifungal effects of clotrimazole-containing mucoadhesive thermosensitive gels on vaginitis. J Control Release 2002,82(1),39-50","journal-title":"J Control Release"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S0168-3659(02)00077-9","volume":"81","author":"Kast C.E.","year":"2002","unstructured":"Kast C.E.; Valenta C.; Leopold M.; Bernkop-Schn\u00fcrch A.; Design and in vitro evaluation of a novel bioadhesive vaginal drug delivery system for clotrimazole. J Control Release 2002,81(3),347-354","journal-title":"J Control Release"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1081\/DDC-100105179","volume":"27","author":"Ceschel G.C.","year":"2001","unstructured":"Ceschel G.C.; Maffei P.; Lombardi Borgia S.; Ronchi C.; Rossi S.; Development of a mucoadhesive dosage form for vaginal administration. Drug Dev Ind Pharm 2001,27(6),541-547","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=85","first-page":"57","volume":"20","author":"Ameen D.W.","year":"2011","unstructured":"Ameen D.W.; Development and in vitro evaluation of bioadhesive vaginal tablet using econazole nitrate as a model drug. Iraqi J Pharm Sci 2011,20(1),57-65","journal-title":"Iraqi J Pharm Sci"},{"key":"ref=86","first-page":"337","volume":"56","author":"Sharma G.","year":"2006","unstructured":"Sharma G.; Jain S.; Tiwary A.K.; Kaur G.; Once daily bioadhesive vaginal clotrimazole tablets: design and evaluation. Acta Pharm 2006,56(3),337-345","journal-title":"Acta Pharm"},{"key":"ref=87","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijpharm.2007.08.042","volume":"350","author":"Wang L","year":"2008","unstructured":"Wang L; Tang X.; A novel ketoconazole bioadhesive effervescent tablet for vaginal delivery: design, in vitro and \u2018in vivo\u2019 evaluation. Int J Pharm 2008,350(1-2),181-187","journal-title":"Int J Pharm"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"339","DOI":"10.4314\/tjpr.v9i4.58924","volume":"9","author":"Bhat S.","year":"2010","unstructured":"Bhat S.; Shivakumar H.G.; Bioadhesive controlled release clotrimazole vaginal tablets. Trop J Pharm Res 2010,9(4),339-346","journal-title":"Trop J Pharm Res"},{"key":"ref=89","first-page":"656","volume":"2","author":"Geeta P.M.","year":"2010","unstructured":"Geeta P.M.; Patel A.P.; A novel effervescent bioadhesive vaginal tablet of ketoconazole: formulation and in-vitro evaluation. Int J Pharm Tech Res 2010,2(1),656-667","journal-title":"Int J Pharm Tech Res"},{"key":"ref=90","first-page":"418","volume":"4","author":"Patel A.","year":"2012","unstructured":"Patel A.; Patel J.; Patel J.; Design, development and in vitro evaluation of sertaconazole mucoadhesive vaginal tablet. Der Pharmacia Lettre 2012,4(2),418-427","journal-title":"Der Pharmacia Lettre"},{"key":"ref=91","first-page":"176","volume":"1","author":"Dangi A.A.","year":"2011","unstructured":"Dangi A.A.; Sheth N.R.; Patel H.J.; Formulation and evaluation of once daily mucoadhesive vaginal tablet of clotrimazole using natural and synthetic polymers. Asian J Pharm Health Sci 2011,1,176-182","journal-title":"Asian J Pharm Health Sci"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2478\/acph-2013-0027","volume":"63","author":"Gupta N.V.","year":"2013","unstructured":"Gupta N.V.; Natasha S.; Getyala A.; Bhat R.S.; Bioadhesive vaginal tablets containing spray dried microspheres loaded with clotrimazole for treatment of vaginal candidiasis. Acta Pharm 2013,63(3),359-372","journal-title":"Acta Pharm"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"407","DOI":"10.2478\/v10007-008-0023-2","volume":"58","author":"Ahmad F.J.","year":"2008","unstructured":"Ahmad F.J.; Alam M.A.; Khan Z.I.; Khar R.K.; Ali M.; Development and in vitro evaluation of an acid buffering bioadhesive vaginal gel for mixed vaginal infections. Acta Pharm 2008,58(4),407-419","journal-title":"Acta Pharm"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"417","DOI":"10.4236\/pp.2012.34056","volume":"3","author":"Karavana S.Y.","year":"2012","unstructured":"Karavana S.Y.; Ren\u00e7be S.; \u015eenyi\u011fit Z.A.; Balo\u011flu E.; A new in-situ gel formulation of itraconazole for vaginal administration. Pharmacol Pharm 2012,3(04),417","journal-title":"Pharmacol Pharm"},{"key":"ref=95","first-page":"358","volume":"1","author":"Hani U","unstructured":"Hani U; Shivakumar HG; Development of miconazole nitrate thermosensitive bioadhesivevaignal gel for vaginal candidiasis. Open J Adv Drug Deliv 2013, 30,1(3),358-368","journal-title":"Open J Adv Drug Deliv"},{"key":"ref=96","doi-asserted-by":"publisher","DOI":"10.1208\/pt070238","volume":"7","author":"Bilensoy E.","year":"2006","unstructured":"Bilensoy E.; Rouf M.A.; Vural I.; \u0160en M.; Hincal A.A.; Mucoadhesive, thermosensitive, prolonged-release vaginal gel for clotrimazole:\u03b2-cyclodextrin complex. AAPS PharmSciTech 2006,7(2)","journal-title":"AAPS PharmSciTech"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1081\/DDC-54315","volume":"31","author":"Ning M.","year":"2005","unstructured":"Ning M.; Guo Y.; Pan H.; Chen X.; Gu Z.; Preparation, in vitro and in vivo evaluation of liposomal\/niosomal gel delivery systems for clotrimazole. Drug Dev Ind Pharm 2005,31(4-5),375-383","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3109\/10611861003649712","volume":"18","author":"Kang J.W.","year":"2010","unstructured":"Kang J.W.; Davaa E.; Kim Y.T.; Park J.S.; A new vaginal delivery system of amphotericin B: a dispersion of cationic liposomes in a thermosensitive gel. J Drug Target 2010,18(8),637-644","journal-title":"J Drug Target"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/jac\/44.3.397","volume":"44","author":"Carrillo-Mu\u00f1oz A.J.","year":"1999","unstructured":"Carrillo-Mu\u00f1oz A.J.; Quind\u00f3s G.; Tur C.; Ruesga M.T.; Miranda Y.; del Valle O.; Cossum P.A.; Wallace T.L.; In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole. J Antimicrob Chemother 1999,44(3),397-401","journal-title":"J Antimicrob Chemother"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/jps.22785","volume":"101","author":"Basnet P.","year":"2012","unstructured":"Basnet P.; Hussain H.; Tho I.; Skalko-Basnet N.; Liposomal delivery system enhances anti-inflammatory properties of curcumin. J Pharm Sci 2012,101(2),598-609","journal-title":"J Pharm Sci"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"967","DOI":"10.4314\/tjpr.v16i5.1","volume":"16","author":"Kaur S.","year":"2017","unstructured":"Kaur S.; Narang R.K.; Aggarwal G.; Formulation and development of colon-targeted mucopenetrating metronidazole nanoparticles. Trop J Pharm Res 2017,16(5),967-973","journal-title":"Trop J Pharm Res"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.carbpol.2016.04.041","volume":"147","author":"Rudzinski W.E.","year":"2016","unstructured":"Rudzinski W.E.; Palacios A.; Ahmed A.; Lane M.A.; Aminabhavi T.M.; Targeted delivery of small interfering RNA to colon cancer cells using chitosan and PEGylated chitosan nanoparticles. Carbohydr Polym 2016,147,323-332","journal-title":"Carbohydr Polym"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1021\/acs.biomac.5b01480","volume":"17","author":"Craparo E.F.","year":"2016","unstructured":"Craparo E.F.; Porsio B.; Sardo C.; Giammona G.; Cavallaro G.; Pegylated polyaspartamide\u2013polylactide-based nanoparticles penetrating cystic fibrosis artificial mucus. Biomacromolecules 2016,17(3),767-777","journal-title":"Biomacromolecules"}],"container-title":["Current Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/183017","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/183017\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/183017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T22:57:00Z","timestamp":1746572220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/183017\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,16]]},"references-count":103,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,8,16]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573405616666200621200047","relation":{},"ISSN":["1874-4672"],"issn-type":[{"value":"1874-4672","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,16]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-10-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-25","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-02-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}